Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05447923 · ClinicalTrials.gov registry record · NA
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
A NA study of Colorectal Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 1
- Study location
NCT05447923 is a NA study of Colorectal Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 450 participants, below the 1,088-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05447923, a NA study of Colorectal Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Educational Intervention
- BEHAVIORAL Patient Navigation
- OTHER Fecal Immunochemical Test
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2022-05-22 |
| Est. Completion | 2030-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05447923
The ClinicalTrials.gov registry entry for NCT05447923 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,088-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (59% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT05447923 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05447923 about?
NCT05447923 is a clinical study titled "Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities". This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United ...
What is the current status of trial NCT05447923?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2022-05-22. Estimated completion is 2030-06-01.
What conditions does trial NCT05447923 study?
This clinical trial studies the following conditions: Colorectal Carcinoma.
What interventions are being tested in trial NCT05447923?
The interventions under investigation include: Questionnaire Administration (OTHER), Educational Intervention (OTHER), Patient Navigation (BEHAVIORAL), Fecal Immunochemical Test (OTHER).
Who is sponsoring clinical trial NCT05447923?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05447923 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
RECRUITING · NA
-
Confronting Cancer as a Community
RECRUITING · NA
-
CoGENES Randomized Controlled Trial (RCT)
RECRUITING · NA
-
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
RECRUITING · NA
-
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
RECRUITING · NA
-
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.